Option Care Health (NASDAQ:OPCH) Updates FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.590-1.690 for the period, compared to the consensus earnings per share estimate of 1.330. The company issued revenue guidance of $5.3 billion-$5.5 billion, compared to the consensus revenue estimate of $5.3 billion.

Option Care Health Trading Up 1.4 %

Shares of OPCH stock opened at $34.60 on Thursday. The firm has a market capitalization of $5.72 billion, a P/E ratio of 29.08, a P/E/G ratio of 2.30 and a beta of 1.33. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.85. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock’s fifty day simple moving average is $29.38 and its 200 day simple moving average is $28.14.

Wall Street Analyst Weigh In

A number of research firms have commented on OPCH. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and upped their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group initiated coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Barrington Research boosted their price objective on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Finally, Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $32.88.

Insiders Place Their Bets

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.